An Update on Inflammatory Bowel Disease

被引：365
作者：
Sairenji, Tomoko [1 ]
Collins, Kimberly L. [2 ]
Evans, David V. [1 ]
机构：
[1] Univ Washington, Dept Family Med, 1959 Northeast Pacific St E-304, Seattle, WA 98195 USA
[2] Univ Washington, Dept Family Med, 331 NE Thornton Pl, Seattle, WA 98125 USA
来源：
PRIMARY CARE | 2017年 / 44卷 / 04期
关键词：
Inflammatory bowel disease; Ulcerative colitis; Crohn disease; Diagnosis; Treatment; Special populations; Pediatric patients; Elderly patients; SIDED ULCERATIVE-COLITIS; QUALITY-OF-LIFE; CROHNS-DISEASE; MEDICAL-MANAGEMENT; MAINTENANCE THERAPY; FECAL CALPROTECTIN; METAANALYSIS; GUIDELINES; EFFICACY; BUDESONIDE;
D O I：
10.1016/j.pop.2017.07.010
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Inflammatory bowel disease (IBD) includes 2 chronic idiopathic inflammatory diseases: ulcerative colitis and Crohn disease. The incidence and prevalence of IBD is increasing worldwide. It can affect people of all ages, including children and geriatric populations, and can affect all aspects of life. In this article, diagnosis and treatment of IBD in adult, pediatric, pregnant, and elderly populations are explored from the perspective of a primary care physician.
引用
收藏
页码：673 / +
页数：21
相关论文
共 103 条
[1]   MECHANISMS OF DISEASE Inflammatory Bowel Disease [J].
Abraham, Clara ;
Cho, Judy H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (21) :2066-2078
[2]   Inflammatory bowel disease in Iran: A review of 457 cases [J].
Aghazadeh, R ;
Zali, MR ;
Bahari, A ;
Amin, K ;
Ghahghaie, F ;
Firouzi, F .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (11) :1691-1695
[3]  
Akiho Hirotada, 2015, World J Gastrointest Pathophysiol, V6, P219, DOI 10.4291/wjgp.v6.i4.219
[4]   Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease [J].
Akobeng, AK ;
Gardener, E .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01)
[5]   Methotrexate for induction of remission in refractory Crohn's disease [J].
Alfadhli, AAF ;
McDonald, JWD ;
Feagan, BG .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01)
[6]   Budesonide versus prednisone in the treatment of active Crohn's disease [J].
Bar-Meir, S ;
Chowers, Y ;
Lavy, A ;
Abramovitch, D ;
Sternberg, A ;
Leichtmann, G ;
Reshef, R ;
Odes, S ;
Moshkovitz, M ;
Bruck, R ;
Eliakim, R ;
Maoz, E ;
Mittmann, U .
GASTROENTEROLOGY, 1998, 115 (04) :835-840
[7]   Tumor necrosis factor-alpha antibody for maintenace of remission in Crohn's disease [J].
Behm, B. W. ;
Bickston, S. J. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01)
[8]   Traditional corticosteroids for induction of remission in Crohn's disease [J].
Benchimol, E., I ;
Seow, C. H. ;
Steinhart, A. H. ;
Griffiths, A. M. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02)
[9]   Clustering in Time of Familial IBD Separates Ulcerative Colitis from Crohn's Disease [J].
Bengtson, May-Bente ;
Solberg, Camilla ;
Aamodt, Geir ;
Jahnsen, Jorgen ;
Bjorn, Moum ;
Sauar, Jostein ;
Vatn, Morten H. .
INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) :1867-1874
[10]  
Bernstein C N, 2001, Curr Gastroenterol Rep, V3, P477
12345678910